CD44 and breast cancer: In accordance with this, Sabol et al. showed that patient-derived xenograft (PDX) tumors co-cultured with obese ASCs increased the formation of metastases and the number of CD44+CD24− breast cancer stem cells in a severely immunodeficient (SCID) mouse model [124].